- Presentations
- 2
- Markets
- 1
Hympavzi is a brand of Marstacimab marketed by Pfizer Laboratories, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Marstacimab
- Brand owner
- Pfizer Laboratories
- Registered in
- United States
- Strengths and forms
- 150 mg/1 mL injection, 75 mg/0.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Hympavzi 150 mg/1 mL injectionSubcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
| Hympavzi 75 mg/0.5 mL injectionSubcutaneous Cold chain | Pfizer Laboratories | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Hympavzi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.